Shares in dual listed healthcare product company Ebos have plummeted on news the company has missed out on a lucrative supply agreement with Chemist Warehouse Australia to its smaller trans-Tasman rival, Sigma Healthcare.
Ebos was placed into a trading halt this morning so the company could digest
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
